What is the significance of a 1.8 cm hypoattenuating right thyroid nodule that meets American College of Radiology (ACR) criteria for further evaluation with dedicated thyroid ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I strongly recommend scheduling a dedicated thyroid ultrasound to further evaluate the 1.8 cm hypoattenuating right thyroid nodule found on your CT chest, as it meets the American College of Radiology (ACR) criteria for additional assessment. This follow-up is necessary to provide more detailed information about the nodule's characteristics, including whether it is solid or fluid-filled, its exact size, blood flow patterns, and features that might suggest benign or potentially concerning properties 1.

Importance of Ultrasound Evaluation

The ultrasound evaluation is crucial in assessing the risk of malignancy in thyroid nodules. According to the ACR Appropriateness Criteria, thyroid nodules larger than 1 cm should be evaluated further with ultrasound, and fine-needle aspiration (FNA) should be considered if suspicious features are present 1.

Next Steps After Ultrasound

Based on the ultrasound findings, your doctor may recommend additional steps such as fine needle aspiration (biopsy) if certain suspicious features are present, such as hypoechogenicity, microcalcifications, or irregular borders 1. The biopsy results will be categorized according to the Bethesda System for Reporting Thyroid Cytopathology, which will guide further management decisions 1.

Molecular Diagnostic Testing

Molecular diagnostic testing may also be useful in evaluating FNA samples that are indeterminate, to assist in management decisions 1. The presence of certain mutations, such as BRAF V600E, can increase the suspicion of malignancy and guide further treatment.

Conclusion and Recommendation

In summary, a dedicated thyroid ultrasound is essential for further evaluating the 1.8 cm hypoattenuating right thyroid nodule, and additional steps such as fine needle aspiration (biopsy) and molecular diagnostic testing may be necessary based on the ultrasound findings. The ultrasound should be scheduled promptly, ideally within the next few weeks, and you should bring your CT chest report to the appointment for comparison.

From the Research

Thyroid Nodule Evaluation

  • The presence of a hypoattenuating right thyroid nodule measuring at least 1.8 cm warrants further evaluation with dedicated thyroid ultrasound, as it meets the ACR criteria 2, 3.
  • Fine needle aspiration biopsy (FNAB) is a crucial step in the evaluation of thyroid nodules, especially those with suspicious clinical findings or ultrasound features suggestive of malignancy 2, 4, 5, 6.

Ultrasound-Guided Fine-Needle Aspiration

  • Ultrasound-guided fine-needle aspiration biopsy (US-FNAB) allows for real-time visualization of the needle and is essential for lowering the yield of nondiagnostic specimens and false-negative results 2, 5.
  • The use of US-guidance for FNAB is highly operator-dependent, and a standardized and meticulous technique is necessary to increase diagnostic results 2, 5.

Diagnostic Features of Thyroid Nodules

  • Certain morphological sonographic features, such as microcalcifications, coarse internal calcifications, and infiltrative or microlobulated margins, are significantly more common among malignant lesions 3.
  • Characteristics that are statistically significantly associated with benignity include peripheral calcification and purely cystic composition 3.
  • The presence of colloid on both ultrasound and cytology may be found in malignant lesions, whereas microcalcifications can sometimes be found in benign lesions 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.